Skip to content

suiteHEART 4.0.6

by Neosoft, LLC

suiteHEART 4.0.6 is a Class II device made by Neosoft, LLC, cleared under FDA 510(k) K130228 on 20 Mar 2013 and listed in FDA GUDID since 29 May 2018 (UDI-DI 00864747000279), active (FDA 510(k)), not in commercial distribution (GUDID) as of 22 Oct 2026.

Active United States. Also listed in GUDID (US), not in commercial distribution.

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

510(k) K130228

FDA submission, from GUDID

Trust

Unverified

Source GUDID, synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number00864747000279 UDI-DI Date29 May 2018ListedStatusListed GUDID: not in commercial distribution
United StatesFDA 510(k)SESE from GUDID Substantially Equivalent · Traditional NumberK130228 Date20 Mar 2013DecidedStatusActive

Official records

Across registries

2 registries list this device

  • FDA 510(k) K130228 decided 20 Mar 2013 Active
  • FDA GUDID UDI-DI 00864747000279 listed 29 May 2018 Listed

Timeline

2 dated events

  1. Cleared FDA 510(k) K130228
  2. Listed FDA GUDID 00864747000279

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

GUDID

Trade name
suiteHEART
Generic name
MRI system application software
Model / reference
4.0.6
Primary DI / UDI-DI
00864747000279
510(k) Number
FDA product code
LLZ
GMDN term
MRI system application software
Device class
Class II
Regulation number
892.2050
GUDID distribution status
Not in Commercial Distribution

Similar devices

Other devices filed under FDA product code LLZ (System, Image Processing, Radiological).

Other devices from Neosoft, LLC

  • suiteDXT Software

    Class I
  • Cake 3.0.0

    Class II
  • suiteHEART 5

    Class II
  • Suiteheart

    Class II

Properties

  • Prescription use
Other properties (14, all answered No)